Form 4: Fulgent Genetics President and COO Jian Xie Reports Tax Withholding Transaction
SEC Form 4
Jian Xie, President and COO of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 23, 2024, Jian Xie, the President and COO of Fulgent Genetics, had 2,612 shares of common stock withheld to satisfy tax obligations.
- The withholding occurred at a price of $24.06 per share.
- Following the transaction, Mr. Xie directly owns 339,110 shares of Fulgent Genetics common stock.
- Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.
Sentiment
Score: 5
Explanation: This is a neutral event related to tax obligations and doesn't indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is required by the SEC to provide transparency regarding the holdings and transactions of company executives.
Key Dates
| Date | Description |
|---|---|
| January 27, 2010 | Date of The Hsieh Family Dynasty Trust |
| February 23, 2023 | Date of restricted stock units grant |
| February 27, 2023 | Date Form 4 was filed reporting the restricted stock units grant |
| February 23, 2024 | Date of the tax withholding transaction |
| February 27, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.